Scrutinizing the therapeutic and diagnostic potential of nanotechnology in thyroid cancer: Edifying drug targeting by nano-oncotherapeutics

E Ghazy, A Kumar, M Barani, I Kaur, A Rahdar… - Journal of Drug Delivery …, 2021 - Elsevier
The dearth of potential of diagnostic and treatment methods hinders the fight against tumors.
The advances in nanotechnology are emerging, expressing countless latent applications …

Nanotechnological Advancements For The Theranostic Intervention In Anaplastic Thyroid Cancer: Current Perspectives And Future Direction

SS Uppalapati, L Guha, H Kumar… - Current Cancer Drug …, 2024 - ingentaconnect.com
Anaplastic thyroid cancer is the rarest, most aggressive, and undifferentiated class of thyroid
cancer, accounting for nearly forty percent of all thyroid cancer-related deaths. It is caused …

Nanomaterials: a promising multimodal theranostics platform for thyroid cancer

L Li, Z Wang, H Guo, Q Lin - Journal of Materials Chemistry B, 2023 - pubs.rsc.org
Thyroid cancer is the most prevalent malignant neoplasm of the cervical region and
endocrine system, characterized by a discernible upward trend in incidence over recent …

[HTML][HTML] Nanoparticles: Promising Auxiliary Agents for Diagnosis and Therapy of Thyroid Cancers

E Froehlich, R Wahl - Cancers, 2021 - mdpi.com
Simple Summary Thyroid cancer (TC) is rare relative to cancers of many other organs
(breast, prostate, lung, and colon). The majority of TCs are differentiated tumors that are …

Current Application of Nanoparticle Drug Delivery Systems to the Treatment of Anaplastic Thyroid Carcinomas

C Wang, Y Zhang - International Journal of Nanomedicine, 2023 - Taylor & Francis
Anaplastic thyroid carcinomas (ATCs) are a rare subtype of thyroid cancers with a low
incidence but extremely high invasiveness and fatality. The treatment of ATCs is very …

Recent advances in theranostic applications of nanomaterials in cancer

F Ahmed, MA Khan, N Haider… - Current …, 2022 - ingentaconnect.com
Early detection and accurate monitoring are two critical factors affecting the outcome of
anticancer therapy. However, both these factors are affected by the limitations of …

Advanced nanomedicine and cancer: Challenges and opportunities in clinical translation

J Gonzalez-Valdivieso, A Girotti, J Schneider… - International Journal of …, 2021 - Elsevier
Cancer has reached pandemic dimensions in the whole world. Although current medicine
offers multiple treatment options against cancer, novel therapeutic strategies are needed …

Nanotechnology in cancer diagnostics and therapeutics: a review

N Yadav, T Dahiya, AK Chhillar… - Current …, 2022 - ingentaconnect.com
Cancer is the uncontrolled proliferation of cells that involves accumulation of genetic
mutations by different types of mutagens including physical, chemical, and biological …

[HTML][HTML] Progress of cancer nanotechnology as diagnostics, therapeutics, and theranostics nanomedicine: preclinical promise and translational challenges

S Alshehri, SS Imam, M Rizwanullah, S Akhter… - Pharmaceutics, 2020 - mdpi.com
Early detection, right therapeutic intervention, and simultaneous effectiveness mapping are
considered the critical factors in successful cancer therapy. Nevertheless, these factors …

Theranostic aspects: treatment of cancer by nanotechnology

B Sarkar, P Paira - Mini reviews in medicinal chemistry, 2018 - ingentaconnect.com
Theranostic agents or theranostic imaging as its name suggests is a combination of two
terms-'diagnosis'& 'therapy'. Efforts are being made to combine both the terms into clinical …